PTCT · Categories · Upgrades
PTCT - Analyst upgrades
PTC Therapeutics Inc. (PTCT) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for PTCT
- PTC Therapeutics upgraded by Citigroup with a new price targetCitigroup upgraded PTC Therapeutics from Neutral to Buy and set a new price target of $108.00
- PTC Therapeutics upgraded by Jefferies with a new price targetJefferies upgraded PTC Therapeutics from Hold to Buy and set a new price target of $85.00
- PTC Therapeutics upgraded by TD Cowen with a new price targetTD Cowen upgraded PTC Therapeutics from Hold to Buy and set a new price target of $90.00
- PTC Therapeutics upgraded by BofA Securities with a new price targetBofA Securities upgraded PTC Therapeutics from Neutral to Buy and set a new price target of $68.00
- PTC Therapeutics upgraded by Citigroup with a new price targetCitigroup upgraded PTC Therapeutics from Sell to Neutral and set a new price target of $40.00
- PTC Therapeutics upgraded by BofA Securities with a new price targetBofA Securities upgraded PTC Therapeutics from Underperform to Neutral and set a new price target of $55.00 from $41.00 previously
- PTC Therapeutics upgraded by Morgan Stanley with a new price targetMorgan Stanley upgraded PTC Therapeutics from Equal-Weight to Overweight and set a new price target of $67.00 from $45.00 previously
- PTC Therapeutics upgraded by RBC Capital Mkts with a new price targetRBC Capital Mkts upgraded PTC Therapeutics from Sector Perform to Outperform and set a new price target of $63.00 from $39.00 previously
- PTC Therapeutics upgraded by Raymond JamesRaymond James upgraded PTC Therapeutics from Underperform to Mkt Perform
- PTC Therapeutics upgraded by Oppenheimer with a new price targetOppenheimer upgraded PTC Therapeutics from Perform to Outperform and set a new price target of $165.00
- PTC Therapeutics upgraded by RBC Capital with a new price targetRBC Capital upgraded PTC Therapeutics from Underperform to Sector Perform and set a new price target of $47.00